×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CPRX – catalyst pharmaceuticals, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CPRX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/16
08:03 am
cprx
Catalyst Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Low
Report
Catalyst Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
12/10
01:02 am
cprx
Santhera Receives Positive Recommendation from NICE for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy [Yahoo! Finance]
Low
Report
Santhera Receives Positive Recommendation from NICE for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy [Yahoo! Finance]
12/3
01:51 pm
cprx
Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock's On An Uptrend: Are Strong Financials Guiding The Market? [Yahoo! Finance]
Low
Report
Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock's On An Uptrend: Are Strong Financials Guiding The Market? [Yahoo! Finance]
12/3
11:04 am
cprx
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick [Yahoo! Finance]
Low
Report
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick [Yahoo! Finance]
12/2
03:48 pm
cprx
Why Catalyst Pharmaceutical (CPRX) is a Top Value Stock for the Long-Term [Yahoo! Finance]
Low
Report
Why Catalyst Pharmaceutical (CPRX) is a Top Value Stock for the Long-Term [Yahoo! Finance]
11/27
11:17 am
cprx
Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Momentum Stock [Yahoo! Finance]
Low
Report
Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Momentum Stock [Yahoo! Finance]
11/25
08:12 am
cprx
Catalyst Pharmaceuticals Recognized as One of North America's Fastest-Growing Companies on the 2024 Deloitte Technology Fast 500™ List [Yahoo! Finance]
Low
Report
Catalyst Pharmaceuticals Recognized as One of North America's Fastest-Growing Companies on the 2024 Deloitte Technology Fast 500™ List [Yahoo! Finance]
11/25
08:03 am
cprx
Catalyst Pharmaceuticals Recognized as One of North America’s Fastest-Growing Companies on the 2024 Deloitte Technology Fast 500™ List
Medium
Report
Catalyst Pharmaceuticals Recognized as One of North America’s Fastest-Growing Companies on the 2024 Deloitte Technology Fast 500™ List
Date
Time
Symbol
Company Name
Action
%Chg
11/6/2024
04:12 pm
cprx
catalyst pharmaceuticals, inc.
BEAT
Report
2.1%
catalyst pharmaceuticals, inc.
8/7/2024
04:11 pm
cprx
catalyst pharmaceuticals, inc.
BEAT
Report
7.6%
catalyst pharmaceuticals, inc.
5/8/2024
04:16 pm
cprx
catalyst pharmaceuticals, inc.
BEAT
Report
3.6%
catalyst pharmaceuticals, inc.
2/28/2024
06:03 pm
cprx
catalyst pharmaceuticals, inc.
MISS
Report
8.8%
catalyst pharmaceuticals, inc.
Date
Time
Symbol
Headline
Impact
12/17
05:25 pm
cprx
Form 4 CATALYST PHARMACEUTICALS For: Dec 13 Filed by: Miller Steve
Low
Report
Form 4 CATALYST PHARMACEUTICALS For: Dec 13 Filed by: Miller Steve
12/11
05:01 pm
cprx
Form 4 CATALYST PHARMACEUTICALS For: Dec 09 Filed by: Elsbernd Brian
Medium
Report
Form 4 CATALYST PHARMACEUTICALS For: Dec 09 Filed by: Elsbernd Brian
12/11
05:01 pm
cprx
Form 4 CATALYST PHARMACEUTICALS For: Dec 09 Filed by: INGENITO GARY
Medium
Report
Form 4 CATALYST PHARMACEUTICALS For: Dec 09 Filed by: INGENITO GARY
12/11
05:01 pm
cprx
Form 4 CATALYST PHARMACEUTICALS For: Dec 09 Filed by: Thompson Tamar
Medium
Report
Form 4 CATALYST PHARMACEUTICALS For: Dec 09 Filed by: Thompson Tamar
12/11
05:01 pm
cprx
Form 4 CATALYST PHARMACEUTICALS For: Dec 09 Filed by: Tierney David S
Medium
Report
Form 4 CATALYST PHARMACEUTICALS For: Dec 09 Filed by: Tierney David S
12/11
05:01 pm
cprx
Form 4 CATALYST PHARMACEUTICALS For: Dec 09 Filed by: Miller Steve
Medium
Report
Form 4 CATALYST PHARMACEUTICALS For: Dec 09 Filed by: Miller Steve
12/11
05:00 pm
cprx
Form 4 CATALYST PHARMACEUTICALS For: Dec 09 Filed by: MCENANY PATRICK J
Medium
Report
Form 4 CATALYST PHARMACEUTICALS For: Dec 09 Filed by: MCENANY PATRICK J
12/11
05:00 pm
cprx
Form 4 CATALYST PHARMACEUTICALS For: Dec 09 Filed by: Del Carmen Jeffrey
Medium
Report
Form 4 CATALYST PHARMACEUTICALS For: Dec 09 Filed by: Del Carmen Jeffrey
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
5/9
Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating.
15.9%
5/14 Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) was given a new $9.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock. 12.7%
4/8 Catalyst Pharmaceuticals Provides Update on Impact of COVID-19 Pandemic on its Business Activities 11.5%
1/6 Catalyst Pharmaceuticals Pre-Announces Estimated Firdapse® Revenues and Provides Updates on Advancement of Clinical Development Programs 11.1%
3/10 Catalyst Pharmaceuticals to Hold Fourth Quarter and Year-End Financial Results and Corporate Update Conference Call and Webcast on Tuesday, March 17th, 2020 9.8%
2/5 Form 8-K CATALYST PHARMACEUTICALS For: Feb 04 9.5%
3/16 Q4/2019 12/31/2019 EPS 0.070 ZacksConsensus 0.090 ActVsEst (0.020) - Miss 8.6%
6/12 Catalyst Pharmaceuticals Files Federal Lawsuit Against U.S. Food and Drug Administration 7.9%
11/13 Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) had its price target lowered by analysts at Piper Jaffray Companies from $8.00 to $7.00. 5.6%
9/24 Form 8-K CATALYST PHARMACEUTICALS For: Sep 23 5.5%
5/14 Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) was given a new $9.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock. 12.7%
4/8 Catalyst Pharmaceuticals Provides Update on Impact of COVID-19 Pandemic on its Business Activities 11.5%
1/6 Catalyst Pharmaceuticals Pre-Announces Estimated Firdapse® Revenues and Provides Updates on Advancement of Clinical Development Programs 11.1%
3/10 Catalyst Pharmaceuticals to Hold Fourth Quarter and Year-End Financial Results and Corporate Update Conference Call and Webcast on Tuesday, March 17th, 2020 9.8%
2/5 Form 8-K CATALYST PHARMACEUTICALS For: Feb 04 9.5%
3/16 Q4/2019 12/31/2019 EPS 0.070 ZacksConsensus 0.090 ActVsEst (0.020) - Miss 8.6%
6/12 Catalyst Pharmaceuticals Files Federal Lawsuit Against U.S. Food and Drug Administration 7.9%
11/13 Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) had its price target lowered by analysts at Piper Jaffray Companies from $8.00 to $7.00. 5.6%
9/24 Form 8-K CATALYST PHARMACEUTICALS For: Sep 23 5.5%
TOP News Decliners
3/15
Catalyst Pharmaceuticals Q4 2019 Earnings Preview [Seeking Alpha]
-23.2%
9/11 Catalyst Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock -14.9%
10/30 Catalyst Pharmaceuticals Announces Top-Line Results of CMS-001, a Phase 3 Trial of Firdapse® (Amifampridine Phosphate) in Patients with Congenital Myasthenic Syndromes (CMS) -14.5%
4/14 Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -12.1%
5/13 Form 8-K CATALYST PHARMACEUTICALS For: May 13 -11.7%
8/7 Q2/2019 6/30/2019 EPS 0.100 ZacksConsensus 0.030 ActVsEst 0.070 - Beat -10.7%
2/27 Catalyst Pharmaceuticals Announces Support of Rare Disease Day 2020 -10.3%
12/20 Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. -8.9%
9/13 Form 8-K CATALYST PHARMACEUTICALS For: Sep 13 -8.0%
11/12 Form 10-Q CATALYST PHARMACEUTICALS For: Sep 30 -7.3%
9/11 Catalyst Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock -14.9%
10/30 Catalyst Pharmaceuticals Announces Top-Line Results of CMS-001, a Phase 3 Trial of Firdapse® (Amifampridine Phosphate) in Patients with Congenital Myasthenic Syndromes (CMS) -14.5%
4/14 Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -12.1%
5/13 Form 8-K CATALYST PHARMACEUTICALS For: May 13 -11.7%
8/7 Q2/2019 6/30/2019 EPS 0.100 ZacksConsensus 0.030 ActVsEst 0.070 - Beat -10.7%
2/27 Catalyst Pharmaceuticals Announces Support of Rare Disease Day 2020 -10.3%
12/20 Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. -8.9%
9/13 Form 8-K CATALYST PHARMACEUTICALS For: Sep 13 -8.0%
11/12 Form 10-Q CATALYST PHARMACEUTICALS For: Sep 30 -7.3%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: